VitalTrace is a cutting-edge medical device company founded in 2017, dedicated to enhancing maternal and neonatal outcomes during labor and delivery. With its headquarters in Australia, the company leverages innovation to develop a pioneering fetal monitoring device.
Backed by Artesian and the Medtech Actuator Program, VitalTrace is setting the stage for transformative advancements in healthcare. They recently secured a Series A investment on 21 September 2023, with participation from key investors such as Artesian and Fund WA. This investment positions them favorably for further growth and development.
VitalTrace's focus on improving childbirth experiences aligns with the growing demand for advanced medical solutions, making it a promising opportunity for investors aiming to make an impact in the healthcare sector.